| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-291X(84)90614-4 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0006291X84906144?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:0006291X84906144?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 6335034 |
| P2093 | author name string | T. P. Singer | |
| Castagnoli N Jr | |||
| A. Trevor | |||
| N. Castagnoli | |||
| J. I. Salach | |||
| P2860 | cites work | Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis | Q22242250 |
| Pargyline Prevents MPTP-Induced Parkinsonism in Primates | Q28266115 | ||
| Monoamine oxidase from beef liver mitochondria: Simplified isolation procedure, properties, and determination of its cysteinyl flavin content | Q41539029 | ||
| Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors | Q48614146 | ||
| Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase | Q48681443 | ||
| Monkey model of Parkinson's disease | Q64765381 | ||
| Iron content and spectral properties of highly purified bovine liver monoamine oxidase | Q70994751 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| suicide | Q10737 | ||
| biophysics | Q7100 | ||
| cell biology | Q7141 | ||
| neurotoxicity | Q3338704 | ||
| P1104 | number of pages | 5 | |
| P304 | page(s) | 831-835 | |
| P577 | publication date | 1984-12-01 | |
| 1984-12-14 | |||
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP | |
| P478 | volume | 125 |
| Q45110846 | 1-Methyl-3-pyrrolines and 2-methylisoindolines: new classes of cyclic tertiary amine monoamine oxidase B substrates |
| Q28238919 | A key amino acid responsible for substrate selectivity of monoamine oxidase A and B |
| Q42504998 | Acetylcholinesterase inhibition by 1-methyl-4-phenylpyridinium ion, a bioactivated metabolite of MPTP. |
| Q68833144 | Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique |
| Q40372752 | Aminium cation radical mechanism proposed for monoamine oxidase B catalysis: are there alternatives? |
| Q33789328 | Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease |
| Q33538239 | Benzylamine analog binding studies as probes of the substrate sites of monoamine oxidases A and B. |
| Q58027874 | Changes of metallothionein i + ii proteins in the brain after l-methyl-4-phenylpyridinium administration in mice |
| Q68820409 | Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion |
| Q48729263 | Chronic exposure to Ro20-1724 protects dopaminergic neurons in vitro against the neurotoxic action of N-methyl-D-aspartate and 1-methyl-4-phenylpyridinium |
| Q38668883 | Clues to the mechanism underlying dopamine cell death in Parkinson's disease |
| Q40437286 | Deficiencies of NADH and succinate dehydrogenases in degenerative diseases and myopathies |
| Q52064896 | Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment. |
| Q42219419 | Evidence for the one-electron oxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+). |
| Q48093061 | Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B. |
| Q45099160 | Further insight into the mode of action of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). |
| Q41056504 | Glutamate and Parkinson's disease |
| Q67934188 | Histochemical localisation of monoamine oxidase A and B in rat brain |
| Q33641852 | Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| Q48273713 | Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice |
| Q72426791 | Inhibition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolic activity of porcine FAD-containing monooxygenase by selective monoamine oxidase-B inhibitors |
| Q42824368 | Inhibition of complex I by hydrophobic analogues of N-methyl-4-phenylpyridinium (MPP+) and the use of an ion-selective electrode to measure their accumulation by mitochondria and electron-transport particles |
| Q71901662 | Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia |
| Q72918902 | Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives |
| Q42853435 | Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases |
| Q46198074 | Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures |
| Q35997651 | Liquid chromatographic-electrospray mass spectrometric determination of 1-methyl-4-phenylpyridine (MPP+) in discrete regions of murine brain |
| Q35069025 | MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain. |
| Q39548164 | MPTP effects on dopamine neurons |
| Q37045190 | MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease |
| Q42001415 | Mechanism-based inactivation of monoamine oxidases A and B by tetrahydropyridines and dihydropyridines |
| Q41484307 | Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B. |
| Q48271571 | Monoamine oxidase-B in astrocytes |
| Q48770292 | Nigrostriatal monoamine oxidase A and B in aging squirrel monkeys and C57BL/6 mice |
| Q37785104 | Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease. |
| Q42854990 | Oxidation and enzyme-activated irreversible inhibition of rat liver monoamine oxidase-B by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). |
| Q46943715 | Oxidation of tertiary amines by monoamine oxidases |
| Q37003217 | Oxidative stress as a cause of Parkinson's disease |
| Q40538595 | Oxidative stress in Parkinson's disease |
| Q44671325 | Placental toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice |
| Q45107956 | Potential latent nitrogen mustard derivatives designed to target monoamine oxidase rich cells |
| Q41741720 | Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite. |
| Q31108497 | Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data |
| Q36916051 | Pyridine Derivatives: Structure-Activity Relationships Causing Parkinsonism-Like Symptoms |
| Q48507765 | Quantitation of a mitochondrial DNA deletion in Parkinson's disease |
| Q48508068 | Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). |
| Q36349357 | Role of astrocytes in MPTP metabolism and toxicity |
| Q53530590 | Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity. |
| Q41161444 | Selective and nonselective effects of 1-methyl-4-phenylpyridinium on oxygen consumption in rat striatal and hippocampal slices |
| Q69923527 | Selective decrease of immunoreactive tyrosine hydroxylase in nigrostriatum of adult male rats after N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment |
| Q48452514 | Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+. |
| Q34322151 | Structural dependence of the inhibition of mitochondrial respiration and of NADH oxidase by 1-methyl-4-phenylpyridinium (MPP+) analogs and their energized accumulation by mitochondria |
| Q69609790 | Studies on the monoamine oxidase (MAO) inhibitory potency of TL-1, isolated from a fungus, Talaromyces luteus |
| Q44057937 | Synthesis and biological evaluation of MAO-A selective 1,4-disubstituted-1,2,3,6-tetrahydropyridinyl substrates |
| Q44868188 | Synthesis and monoamine oxidase B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines |
| Q46070690 | The Neurotoxin l-Methyl-4-Phenyl-l,2,3,6-Tetrahydropyridine (MPTP): A Key to Parkinson's Disease? |
| Q40960334 | The colorful past and bright future of monoamine oxidase research. |
| Q23923841 | Time-dependent slowly-reversible inhibition of monoamine oxidase A by N-substituted 1,2,3,6-tetrahydropyridines |
| Q42101200 | Uptake and accumulation of 1-methyl-4-phenylpyridinium by rat liver mitochondria measured using an ion-selective electrode |
| Q69876986 | Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+ |
| Q48958530 | [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterization. |
Search more.